- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03144180
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques (qcup)
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques: A Feasibility Study
Descripción general del estudio
Descripción detallada
Approximately 4 million babies were born in the United States in 2015. Umbilical cord blood (UBC) collection is a routine hospital procedure done to evaluate a newborn's health after the birth of the fetus. UBC is tested to measure bilirubin levels, blood gases, blood sugar levels, blood types, complete blood counts, and platelet counts. UBC is collected by either draining the blood into the collection vial, milking the umbilical cord of blood, or extracting the blood by injecting a needle with a syringe. The Center for Disease Control (CDC) estimates 5.6 million workers in the health care industry are at risk of occupational exposure to bloodborne pathogens. Occupational exposure during umbilical cord blood collection may occur due to the great deal of blood and amniotic fluid present at the time of delivery. This fluid causes the physician to have a slippery grasp on the umbilical cord and vials for collection. These methods pose a risk of exposing Labor and Delivery staff to blood borne diseases. The drainage and milking method can lead to an increased amount of spilled blood while the extraction method may lead to accidental needle sticks. Exposure to bloodborne pathogens may be amplified when the umbilical cord is engorged with blood and as the needle is inserted in the cord, splatter may occur. The Needlestick Safety and Prevention Act was signed into law on November 6, 2000 in which employees were required to implement safer medical devices. Many patents have been obtained for umbilical cord blood collection devices however, there has not been a standardized method of collecting and transferring umbilical cord blood to the laboratory vacuum tubes. The goal of this project is to prove the feasibility of using the Q-Cup, a patent pending disposable, two-piece blood collection and transfer device for safely and efficiently collecting umbilical cord blood and transferring it into laboratory vacuum tubes.
The overall objective of this project is to prove the feasibility of using a two-piece umbilical blood collection and transfer device for safely and effectively collecting umbilical cord blood and transferring the blood into a laboratory vacuum tube. Also, the investigators will assess provider satisfaction, safety, ease of use, length of procedure comparing passive flow into blood tubes and the Q-cup technology. The Q-Cup technology can take part in the effort to reduce occupation exposures including percutaneous exposures during labor and delivery in general and by studying specifically the heretofore neglected category of umbilical cord blood collection and transfer. Efforts in this area will help focus attention on this previously ignored domain and help establish a standard of care and safety during this frequent procedure.
The investigators hypothesize the Q-Cup will be a more effective transfer method than current practices utilized for umbilical cord blood collection.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Texas
-
El Paso, Texas, Estados Unidos, 79912
- Texas Tech University Health Sciences Center El Paso
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Obstetric patients must be age 18 or older
- Obstetric patients must be receiving prenatal care at Texas Tech University Health Sciences Center El Paso Department of Ob-Gyn
- Obstetric patients must be in their third trimester
- Obstetric patients must be delivering at University Medical Center
Exclusion Criteria:
- children will not be included
- patients in active labor
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control
The Q-cup will not be used to collect umbilical cord blood.
|
|
|
Comparador activo: Study Group
The Q-cup will be used to collect umbilical cord blood.
|
This technology is a different way of collecting umbilical cord blood.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mean Blood Collection Time
Periodo de tiempo: 12 weeks
|
Anticipating the average lengths of cord blood collection with the standard method is 15 seconds and 30 seconds with the Q-cup, we needed 30 subjects total.
15 in the Q-cup arm of the study and 15 in the comparison group (for a two-sided two-sample t-test with 80% power, an alpha of 0.05, and a common standard deviation of 14 seconds).
30 participants were recruited into the study, however, the delivery providers were in charge of collecting this outcome.
|
12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Determining Umbilical Cord Collection Cleanliness With the Q-cup as Compared to the Standard Blood Collection Method
Periodo de tiempo: At Delivery which could be between 1 to 12 weeks after Baseline.
|
Participants' delivery providers were asked to self-administer a survey in which they were to assess blood collection for cleanliness.
Possible choices were excellent/ good or fair/poor.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
At Delivery which could be between 1 to 12 weeks after Baseline.
|
|
Fill Capacity of Umbilical Cord Blood Using the Qcup Compared to Standard of Care
Periodo de tiempo: 12 weeks
|
Participant delivery providers were asked to self-administer a survey in which they were to assess the fill capacity of the lab tubes using the Qcup or the standard method.
Possible choices were filled to capacity and not filled to capacity.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
12 weeks
|
Colaboradores e Investigadores
Investigadores
- Investigador principal: Michael Schaffer, MD, Texas Tech University Health Sciences Center, El Paso
Publicaciones y enlaces útiles
Publicaciones Generales
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- E17020
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Q-cup
-
Limacorporate S.p.aActivo, no reclutando
-
Stryker Trauma GmbHTerminadoNecrosis de la cabeza del fémur | Artrosis primaria | Luxaciones congénitas | Fractura del cuello del fémur | Artrosis postraumática de cadera Nos.
-
Kenneth PalmerUnited States Department of DefenseReclutamientoPrevención de COVID-19Estados Unidos
-
Holland Bloorview Kids Rehabilitation HospitalTerminado
-
Medical University of WarsawReclutamiento
-
Jetema Co., Ltd.Terminado
-
GlaxoSmithKlineTerminado
-
Cynosure, Inc.Terminado
-
Spaulding Rehabilitation HospitalReclutamiento
-
Boston Scientific CorporationTerminadoTaquicardia VentricularEstados Unidos, Países Bajos, Nueva Zelanda, Reino Unido